Decibel Cannabis Company Inc. announced that it has expanded its global footprint by entering into a supply agreement (the "Agreement") to provide premium dried medical cannabis flower to 4C LABS, a healthcare, technology, and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution and clinical development in cannabis based medicinal products for human h ealth in the United Kingdom and Channel Islands (the "UK"). Decibel to supply 4C LABS with Qwest branded, craft-quality Medical Cannabis for distribution to UK medical cannabis patients; Decibel to grant strain exclusivity of rare and unique cultivars to be distributed by 4C LABS; 3-year supply agreement; Initial shipment expected before year end; Minimum purchase commitments achieve exclusivity over certain genetics and QWEST brand in the UK.